FDA Approves RAS Mutation Detection Kit as Companion Diagnos

The FDA has approved the CRCdx® RAS Mutation Detection Kit as a companion diagnostic for panitumumab in the treatment of patients with metastatic colorectal cancer, according to an announcement from EntroGen.

Related Keywords

Matthew Minkovsky , Amgen , Detection Kit , Colorectal Cancer , Fda , Panitumumab , Kras Mutation ,